Introduction
Speci®c chromosomal alterations including translocations, inversions, deletions, and DNA ampli®cation have been identi®ed in a large number of tumor types. Activation of proto-oncogenes of the myc family (cmyc, N-myc, and L-myc) occurs in lung cancer both in the presence and absence of other detectable genetic alterations such as gene ampli®cation and genomic rearrangement. In patients with small cell lung cancer (SCLC), DNA ampli®cation of c-myc is more common in tumor cell lines established from treated than untreated patients' tumors . DNA ampli®cation of c-myc is also associated with the variant form of SCLC cell lines (Little et al., 1983) , which typically have greater cloning eciency in soft agar, shorter doubling time in vitro, altered in vitro and in vivo morphology, and lower expression of markers of neuroendocrine dierentiation compared to the more common classic SCLC cell lines Gazdar et al., 1985) . In contrast, tumors with Lmyc ampli®cation are most commonly of the classic morphology . In patients with previously treated SCLC, the presence of c-myc DNA ampli®cation is associated with shortened survival .
The human L-myc gene (also known as MYCL1) was initially identi®ed in SCLC cell lines and tumors because of DNA ampli®cation of sequences homologous to but dierent from the human c-myc and Nmyc genes and consists of three exons spanning approximately 6.6 kb on chromosome 1p32 . L-myc DNA ampli®cation is found in 18% of SCLC cell lines and 12% of SCLC tumors (Johnson, 1996) . The various sized L-myc transcripts, including 3.9 kb, 3.6 kb, and smaller sized species, result from alternative transcription initiation and termination sites , and all include exons 2 and 3 and a a predicted 364 amino acid protein . Alternative translation initiation from a CTG start site in intron 1 and post-translational modification results in proteins with apparent molecular weight of 60 to 66 kDa (Dosaka-Akita et al., 1991) .
Observation of an abnormally-sized protein on LMyc immunoblots of SCLC cell lines led to identification of the RLF (rearranged L-myc fusion) gene (MaÈ kelaÈ et al., 1991b) , which is 310 kb centromeric to L-myc . Juxtaposition of the RLF and L-myc genes in SCLC cells results in expression of a chimeric RLF-L-myc transcript (MaÈ kelaÈ et al., 1991b) . The resulting chimeric RLF-L-Myc protein, like the wild-type L-Myc protein, inhibits dierentiation in murine embryonic stem cells (MacLean-Hunter et al., 1994) . Characterization of 126 SCLC cell lines at NCI has identi®ed 11 (9%) with Lmyc ampli®cation . We studied these eleven L-myc-ampli®ed cell lines and have identi®ed a novel cyclophilin-like gene located at chromosome 1p32. Co-ampli®cation on this cyclophilin-like gene with L-myc in SCLC cell lines occurs more commonly than co-ampli®cation of RLF with L-myc and can result in expression of chimeric transcripts.
Results

Characterization of RLF in L-myc ampli®ed cell lines
Southern blot analysis of SstI-digested genomic DNA from the L-myc-ampli®ed cell line, NCI-H378, has previously been found to detect a slightly smaller DNA band (3.5 kb) compared to normal genomic DNA when hybridized with an exon 2 L-myc probe (Johnson et al., 1987; . To determine if aberrantsized transcripts are present in this cell line, Northern blot analysis of NCI-H378 and 10 additional L-mycampli®ed cell lines was performed using probes from L-myc exon 2 and exon 3 (Figure 1 ). The abundant Lmyc transcript observed in NCI-H378 by hybridization with either an exon 2 or exon 3 probe was slightly smaller (*3.6 kb) compared with the expected bands (*3.9 and 3.7 kb) (Figure 1 ). Expected-sized transcripts were observed in the other 10 L-myc ampli®ed cell lines. In addition, aberrantly-sized transcripts of approximately 3.2 kb were observed in both NCI-H889 and NCI-H1836 (Figure 1) . No L-myc mRNA was detected in NCI-H289, suggesting that L-myc gene ampli®cation is not invariably associated with overexpression of mRNA.
To determine if RLF rearrangement was responsible for these aberrantly-sized transcripts, Northern blot analysis was performed using a probe containing RLF exon 1 and 2 sequence. This analysis detected transcripts only in NCI-H889 and NCI-H1836 (Figure 1 ). RT ± PCR using an L-myc exon 3-speci®c oligonucleotide (MK60; Table 1 ) as primer for the RT reaction and an oligonucleotide from RLF exon 1 (MK59 ; Table 1 ) and L-myc exon 2 (MK53; Table 1) as PCR primers was also performed on the eleven Lmyc ampli®ed cell lines. Using this technique, chimeric RLF-L-myc transcripts were detected in three of eleven L-myc-ampli®ed cell lines (NCI-H889, NCI-H1836, and NCI-H1994; data not shown) and con®rmed by direct sequencing of the PCR products to contain RLF exon 1 and L-myc exon 2 sequence (MaÈ kelaÈ et al., 1991a) . However, no RLF-L-myc chimeric transcript was detected in NCI-H378. Therefore, the aberrantlysized L-myc transcript in NCI-H378 did not result from a RLF-L-myc gene rearrangement.
To determine the frequency of RLF gene amplification in the NCI L-myc-ampli®ed cell lines, Southern blot analysis of SstI-digested genomic DNA from SCLC cell lines using a full length RLF cDNA as probe was performed (Figure 2 ). Four bands [*15 kb, 12 kb, 5 kb (doublet), and 3.8 kb] were detected in all eleven L-myc-ampli®ed cell lines, as well as in a human B lymphoblastoid cell line (NCI-B1184); a L-mycoverexpressing, non-L-myc ampli®ed cell line (NCI-H209); a c-myc-ampli®ed cell line (NCI-H211); a non-L-myc overexpressing, non-MYC ampli®ed cell line (NCI-H345); and an N-myc-ampli®ed cell line (NCI-H526) (Figure 2a ). Using the control probe (GRP) to Figure 1 Northern blot analysis of L-myc ampli®ed cell lines using probes from L-myc (exon 2 and 3) and RLF. Approximately 20 mg of total cellular RNA was subjected to Northern blot analysis as described in Materials and methods and hybridized sequentially with 32 P-radiolabeled probes from exon 2 and 3 of Lmyc and an RLF probe containing exon 1 and 2 sequence (300 bp EcoRI-HindIII fragment of plasmid a8-1.2). A rat GAPDH cDNA fragment served as a control probe (lower panel). The B lymphoblastoid cell line, B1184, was included as a negative control Provisional assignment of exon number to segments of the PPIE cDNA is based on homology with PPIA intron/exon structure (Haendler and Hofer, 1990) and the assumption of an additional 3' alternatively spliced exon.
b Sequence based on Hellsten et al. normalize band intensities to that of the lymphoblastoid DNA, ampli®cation of RLF was found in four of 11 (36%) L-myc ampli®ed cell lines and none of four non-L-myc ampli®ed lines (Figure 2a ). In two of these RLF-ampli®ed cell lines, NCI-H889 and NCI-H1836, only the 15 kb band was ampli®ed while all four RLF bands were ampli®ed in NCI-H298 and NCI-H1994. A 3' fragment of the RLF probe, which lacks RLF exon 1 sequence, detected three bands of approximately 12 kb, 5 kb and 3.8 kb (Figure 2b ), indicating that the 15 kb band detected with the full length RLF cDNA probe ( Figure 2a ) contains RLF exon 1 sequence and that the ampli®cation of RLF in NCI-H889 and NCI-H1836 was limited to exon 1.
Isolation of L-myc cDNA from NCI-H378
To further characterize the aberrant L-myc transcripts in NCI-H378, an L-myc exon 2 probe was used to screen a cDNA library from NCI-H378. Two cDNA clones (6930 and 6931) containing L-myc exon 2 sequences that did not hybridize with an L-myc exon 1 probe were isolated. DNA sequence analysis of these clones revealed the presence of 213 bp and 94 bp of L-myc exon 2 sequence, respectively. In both clones, the L-myc sequence was in the antisense orientation at the 5' end of the cDNA and terminating at nucleotide 27 of L-myc exon 2 . The inverse complement of nucleotides 26 to 29 of Lmyc exon 2 is TGGT, suggestive of a potential mRNA splice site at this point. The 3' portion of these cDNAs consisted of 575 bp and 536 bp of novel sequence and were identical to each other except for a 39 bp in-frame deletion in the smaller clone (clone 6931; Figure 3 ). Clones 6930 and 6931 both contained poly(A) tails and were predicted to encode proteins of 136 and 145 amino acids, respectively. The 39 bp in-frame deletion A database search identi®ed three expressed sequence tag (EST) clones (81575, 83130 and 97971) with greatest sequence identity (495%) to the novel sequence of clones 6930 and 6931. Lesser degrees of sequence identity (*60 to 80%) were found to segments of the cyclophilin type of peptidyl-prolyl isomerase (PPIase) genes from human, rat drosophila, yeast, Arapidopsis, and other organisms. Thus, the gene giving rise to the novel sequence of clones 6930 and 6931 is designated PPIE to re¯ect this sequence similarity to PPIases, a ubiquitous class of enzymes thought to assist in protein folding by catalyzing the cis-trans isomerization of peptides and proteins. Southern blot hybridization of BamHI-digested human, monkey, horse, chicken, and Xenopus laevis genomic DNAs was performed using a probe from the 3' end of the novel sequence (PPIE 3' probe; Figure  3 ). This probe sequence was selected to avoid crosshybridization with known PPIase gene sequences. Evolutionary conservation of PPIE was con®rmed by the detection of a hybridizing band(s) in all species using high stringency conditions (Figure 4a ).
Isolation of cyclophilin-like cDNAs
To further characterize the novel sequence, a probe from the 5' end of the novel sequence was used to screen a human skeletal muscle cDNA library. Seven clones were isolated and sequenced. The sequence of ®ve of these seven clones formed a 1266 bp consensus cDNA with a 903 bp open reading frame (ORF) predicted to encode a 301 amino acid protein ( Figure  5a ). No upstream, in-frame stop codon was present but the ATG at nucleotides 12 to 14 conforms to the consensus initiation codon. Two of the seven clones had the same divergent sequence beginning at nucleotide 849 of the consensus sequence, suggesting alternative splicing of a 3' exon (tentatively designated exon 6B; Figure 5b ). The divergent sequence of these two clones was the same as that found in clones 6930 and 6931 from NCI-H378 and could encode 17 amino acids. The analogous alternative sequence, tentatively designated exon 6A, encodes 22 amino acids. A polyadenylation signal (nucleotides 1245 ± 1250, Figure  5a ; and nucleotides 1033 to 1038, Figure 5b ) and polyadenylation site were present in both types of cDNAs. There was striking similarity between the predicted skeletal muscle cDNA ORF and the human cyclophilin A (PPIA), cyclophilin B (PPIB), cyclophilin C (PPIC), cyclophilin D (PPID) and cyclophilin-like (PPIL1) protein sequences (Figure 5c ). In the central conserved region of the cyclophilins (corresponding to PPIA amino acids 29 to 132), there was 83, 69, 67 and 56% identity of the predicted ORF with PPIA, PPIB, PPIC, and PPIL1, respectively, including conservation of residues thought to be functionally important for PPIase activity (Zydowsky et al., 1992) . Thus, the novel sequence of the chimeric L-myc-containing cDNAs from NCI-H378 appear to be derived from an undescribed peptidyl-prolyl isomerase gene, PPIE. 
Analysis of PPIE in L-myc-ampli®ed cell lines
Southern blot analysis of BamHI-and EcoRI-digested genomic DNAs was performed using the PPIE 3' probe. A single band of approximately 1.8 kb was detected in the BamHI digested DNA of each cell line. Using the intensity of the signal from a control gene (GRP) to normalize signals between samples, seven of 11 (64%) L-myc-ampli®ed cell lines had between ®vefold to 24-fold ampli®cation of PPIE compared to a B lymphoblastoid cell line (Figure 6a) . A similar analysis using EcoRI-digested genomic DNA from these cell lines detected two bands (approximately 20 kb and 18 kb) hybridizing with the PPIE probe ( Figure 6a ). Interestingly, ampli®cation of the 20 kb and 18 kb PPIE-hybridizing EcoRI fragments can occur independently of each other since the 18 kb band was over represented in NCI-H510 and the 20 kb band was over represented in NCI-H889 (Figure 6a ). Both the 20 and 18 kb bands were ampli®ed in the other cell lines with ampli®cation of PPIE except NCI-H378 which contains only a very intense 18 kb band but no detectable 20 kb band ( Figure 6 ). No ampli®cation of PPIE was observed in four cell lines without L-myc ampli®cation (Figure 6a ).
Pulsed ®eld gel electrophoresis (PFGE)
Southern blot hybridization of MluI-digested genomic DNA from a B lymphoblastoid cell line subjected to PFGE showed that probes from PPIE, L-myc, and RLF each hybridized to a fragment of approximately 800 kb (Figure 6b ), suggesting that these three genes are located on the same 800 kb Mlu fragment. Similar analysis was performed on L-myc-ampli®ed and non-Lmyc ampli®ed cell lines (Figure 6b ). In addition to the 800 kb band found in the lymphoblastoid cell line, the MluI fragments hybridizing with PPIE and L-myc probes were of similar size in each of the L-mycampli®ed cell lines (Figure 6b ). The size of the MluI fragments cohybridized by the L-myc and PPIE probes varied between 100 kb and 1 MB in the L-mycampli®ed cell lines. In NCI-H1836, the PPIE probe also hybridized to three bands of approximately 300, 250 and 100 kb that were not recognized by the L-myc probe. Southern blot hybridization of SstII-digested genomic DNA revealed a single band for all cell lines using a PPIE probe, L-myc probe, and RLF probe (data not shown). As expected, no alterations of these three genes were detected in Southern blots of MluI or SstII digested DNA from the four cell lines without Lmyc ampli®cation (Figure 6b ).
Chromosomal localization of PPIE
PCR analysis of genomic DNA's from a panel of somatic cell hybrids using two oligonucleotide pairs from the apparent alternately spliced 3' exons of PPIE (MK75, MK77 and MK55, MK57; Table 1 ) assigned PPIE to chromosome 1 (data not shown). Similar analysis using a medium resolution radiation hybrid panel to further localize PPIE showed linkage to the anonymous DNA marker, D1S1598 (lod score=5.47 at a b Figure 6 Ampli®cation of PPIE in SCLC cell lines. Southern blot analysis was performed using genomic DNA from a human B lymphoblastoid cell line (NCI-B1184); 11-L-myc ampli®ed cell lines (NCI-H298 to NCI-H2552); an L-myc-overexpressing, non-L-myc ampli®ed cell line (NCI-H209); a c-myc-ampli®ed cell line (NCI-H211); a non-L-myc overexpressing, non-MYC ampli®ed cell line (NCI-H345); and an N-myc-ampli®ed cell line (NCI-H526). Position of migration of size standards is indicated on the left. (a) Genomic DNA was digested with BamHI (upper panel) and EcoRI (lower panel). A fragment from the 3' end of PPIE (see Figure 3 ) was used as probe. Approximately equal amounts of DNA were present in each lane as determained by ethidium bromide staining (data not shown) and cohybridization with the control GRP probe. The fold ampli®cation of PPIE sequences was estimated by calculating the ratio of the signal intensity from the PPIE probe in BamHI-digested DNA and correcting for the intensity of the control GRP probe. Signal intensities were measured using a PhosphorImager and ImageQuant software (Molecular Dynamics). The position of migration of fragments hybridizing with PPIE and GRP are indicated with arrows. (b) Cells were digested with MluI and subjected to pulse ®eld gel electrophoresis as described in Materials and methods. After transfer to a nylon membrane, Southern blot hybridization was performed using a 3' PPIE probe (see Figure 3) , an L-myc exon 2 probe, and a full length RLF cDNA probe. The arrow head in each panel represents the position of the 800 kb fragment hybridizing with each of the three probes in DNA from NCI-B1184 *32 cR 10000 and 6.11 at *24 cR 10000 , respectively). Analysis of this radiation hybrid panel with an RLF exon 6 oligonucleotide pair (2583 and 2584; Table 1 ) and an L-myc exon 3 oligonucleotide pair (MK88 and MK89; Table 1 ) also showed linkage to D1S1598 (lod score=6.87 at *17 cR 10000 and 4.92 at *39 cR 10000 , respectively). Multipoint linkage analysis indicated that the most likely order is RLF-D1S1598-PPIE-L-myc.
PPIE expression in L-myc-ampli®ed cell lines
Abundant transcripts hybridizing to a PPIE probe derived from the sequence of clone 6930 were detected in four of the 11 (36%) L-myc ampli®ed cell lines, NCI-H378, NCI-H510, NCI-H889 and NCI-H1836 (Figure 7 , middle panel). These four cell lines each had gene ampli®cation of PPIE. A transcript similar in size to that found in normal tissues (1.4 kb) was detected in each of these cell lines. Additional bands, possibly due to DNA rearrangements, activation of alternative promoter sequences, or alternative mRNA splicing, were detected in NCI-H378 (1.9 and 3.8 kb), NCI-H889 (1.9 and 3.8 kb), and NCI-H1836 (0.5, 2.8, and 3.0 kb). Using a probe from the 3' alternative sequence found in 5 of the 7 skeletal muscle cDNAs, a single band of approximately 1.8 kb was detected in six cell lines, NCI-378, NCI-H510, NCI-N691, NCI-H1836, NCI-H1994, and NCI-H2552 (Figure 7 , top panel). No PPIE mRNA was detected with either probe in two of the seven cell lines with PPIE gene ampli®cation (NCI-H298 and NCI-H1694). Thus, ampli®cation of the PPIE gene in SCLC cell lines is neither necessary (NCI-N691) nor sucient (NCI-H298 and NCI-H1694) for PPIE expression in SCLC cells.
Discussion
Analysis of the genetic alterations that occur during the multistep carcinogenic process is expected to lead to a better understanding of the biology of lung cancer and to suggest novel therapeutic strategies. In this paper, we have used an approach analogous to that of MaÈ kelaÈ et al. (1991b) to identify a previously uncharacterized cyclophilin-like gene, PPIE, co-ampli®ed with L-myc in human SCLC tumor cell lines. The presence of chimeric transcripts of L-myc antisense sequence and sense PPIE sequence suggests that L-myc and PPIE are oriented in a head-to-head orientation with PPIE 5' of L-myc. Since RLF is located *310 kb 5' of L-myc , the two possible gene orders are RLF-PPIE-L-myc or PPIE-RLF-Lmyc. Coampli®cation of PPIE with L-myc was detected in at least three cell lines without detectable alteration of RLF, a ®nding that strongly suggests L-myc is closer to PPIE than it is to RLF. Therefore, the most likely gene order is RLF-PPIE-L-myc, the order best supported by our radiation hybrid analysis. Another gene previously mapped to the region between RLF and L-myc is PPT , mutations of which are responsible for infantile neuronal ceroid lipofuscinosis .
The chimeric L-myc-PPIE transcript found in NCI-H378 presumably results after activation of an antisense L-myc promoter. Such an antisense promoter has been previously described for c-myc (Celano et al., 1992; Spicer and Sonenshein, 1992) . The 5' end of the cyclophilin-like sequence of the NCI-H378 chimeric transcript is homologous to the 5' end of exon 3 of PPIA and, as previously noted, the 3' end of the L-myc sequence contains a possible splice site sequence. These observations suggest that mRNA splicing occurs to generate this transcript. However, whether activation of an antisense L-myc promoter following L-myc amplification is sucient for expression of the chimeric L-myc-PPIE transcript or gene rearrangement resulting in juxtaposition of L-myc and PPIE is also required has not been addressed by the current study.
The biological signi®cance of expression of PPIE sequences in SCLC cells, either as full length cDNA or L-myc-chimeric transcripts, remains to be determined. Immunophilins (cyclophilins and FK506 binding proteins) are the protein receptors for potent immunosuppressants, including cyclosporin A, FK506, and rapamycin (Schreiber, 1991) and have peptidyl-prolyl cis-trans isomerase activity (Marks, 1996) . Recently, the product of PPID (cyclophilin-40) was implicated in protein folding in conjunction with heat shock proteins, Hsp90 and Hsp70 (Freeman et al., 1996) . However, the functional role of the individual cyclophilins is poorly understood. The tissue expression pattern of PPIE suggests that it may be involved in muscle-and brain-speci®c processes. The segment of PPIE extending N-terminal of the central conserved region is longer than the N-terminal region in PPIA and is unique among the cyclophilins in containing an RNP-1 consensus sequence at amino acids 52 to 59 Figure 7 Northern blot analysis of 11 L-myc ampli®ed cell lines. Northern blot hybridization was performed as described in Materials and methods using 20 mg of total RNA from each of the 11 cell lines. The blots were hybridized with radiolabeled DNA fragments from the two putative 3' alternatively spliced exons (6A and 6B). DNA fragments de®ned by oligonucleotides MK75 and MK77 (putative PPIE exon 6A, upper panel), and MK55 and MK57 (corresponding to sequence of clones 6930, 6931 and putative PPIE exon 6B, middle panel) were radiolabeled with 32 P-a-dCTP using random primer extension. A rat GAPDH probe was used as control for RNA loading and transfer (lower panel) (Figure 5c ), suggesting that it may bind RNA (Bandziulis et al., 1989; Dreyfuss et al., 1988) .
The observation of two bands on Southern blot analysis of EcoRI-digested DNA using a 3' PPIE probe suggests that there may be two genomic sequences hybridizing with this probe. This is supported by the absence of an EcoRI recognition site within the probe; the presence of a single band of the predicted size ampli®ed from human genomic DNA using oligonucleotides that de®ne the PPIE probe (data not shown) indicating that no intron interrupts the probe sequence; and the presence of two bands in samples from 15 of 16 individuals indicating that the bands are unlikely to represent allelic variants. If two PPIE-like sequences are present in the human genome, both are likely to be located near L-myc, on chromosome 1p32 since both EcoRI bands observed by Southern blot can be ampli®ed in L-myc-ampli®ed cell lines. In addition to these questions, further study will be required to determine the prognostic and functional signi®cance of PPIE ampli®cation and expression in SCLC.
Materials and methods
Cell lines and nucleic acid isolation
SCLC cell lines with L-myc DNA ampli®cation, NCI-H298, H378, H462, H510, N691, H889, H1694, H1836, H1994, H2107 and H2552 , and cell lines without L-myc ampli®cation, NCI-H345 (no MYC gene ampli®cation), NCI-H526 (N-myc ampli®cation), NCI-H209 (high level L-myc expression without gene ampli®cation), NCI-H211 (c-myc DNA ampli®cation), and NCI-B1184 (B cell lymphoblastoid line) were grown in appropriate culture medium and harvested for nucleic acid isolation during log phase growth. Genomic DNA was isolated from cell lines using the DNA extraction kit (Stratagene). Total cellular RNA was isolated with the Rapid total RNA isolation kit (5 prime-3 prime) and integrity of the RNA was con®rmed by the presence of 28S and 18S rRNA bands by denaturing gel electrophoresis and a single band upon hybridization of Northern blots with a rat GAPDH probe.
cDNA libraries A cDNA library was constructed in the Charon 4A vector from NCI-H378 poly(A)-selected RNA primed with oligo(dT) 12 . Plaques were screened using a 1.9 kb SmaI-EcoRI L-myc genomic fragment containing exons 2 and 3. Inserts of clones hybridizing to this fragment but not hybridizing to a L-myc exon 1 probe were subcloned into plasmid vectors. A human skeletal muscle cDNA library (Clontech) was screened according to the manufacturer's recommendations. Inserts from hybridizing phage were subcloned into pGEM11zf(7) (Promega). DNA sequence analysis was performed by the dideoxynucleotide chain termination technique in a thermocycler using the fmol cycle sequencing kit (Promega). DNA database comparisons were performed using the BLAST network service at National Center for Biotechnology Information, National Institutes of Health (Altschul et al., 1990) .
Southern and Northern blot hybridization
For Southern hybridizations, 15 mg genomic (or 25.5 mg from Xenopus laevis) DNA was digested with the appropriate restriction enzyme (Life Technologies) and fractionated by 0.8% agarose gel electrophoresis. For Northern blot hybridizations, 20 mg of total cellular RNA was fractionated through denaturing (1% formaldehyde) agarose gels. The human multiple tissue Northern blot was obtained from Clontech. Nucleic acid transfer to nylon membranes (Hybond N + ; Amersham), hybridization, and washing were performed according to the manufacturer's recommendations. L-myc exon 2-and exon 3-speci®c probes consisted of appropriate subclones from a 1.9 kb SmaI-EcoRI L-myc genomic fragment . The control gastrin releasing peptide (GRP) probe is derived from nucleotides 263 to 490 of the cDNA sequence (GenBank accession number K02054) cloned into pGEM11zf(7) (Promega). DNA fragments were radiolabeled with 32 P using the Random Primers DNA Labeling System (Life Technologies) per manufacturers recommendations. The ®nal wash was 0.16SSC and 0.1% SDS at 508C for 15 to 20 min.
RT ± PCR
One microgram of total RNA was annealed with 100 ng of an appropriate antisense oligonucleotide (MK60, Table 1 ) and 100 ng of the control GAPDH oligonucleotide (G3PD2R, Table 1) in 10 ml by heating to 708C for 2 min followed by cooling to room temperature. RT was performed in 22 ml containing 16 ®rst strand buer (Life Technologies), 10 mM DTT (Life Technologies), 50 mM dNTPs (Perkin Elmer), 40 U of RNasin (Promega), and 200 U of MMLV reverse transcriptase (Life Technologies) at 428C for 1 h prior to inactivation of the RT for 5 min at 708C. One microliter of the RT reaction was used as template for PCR using the GeneAmp kit (Perkin Elmer) and 40 cycles of 15 s at 948C, 30 s at 558C, 30 s at 728C, in a Perkin Elmer model 9600 thermocycler. The sequence of oligonucleotides used for PCR (MK59, MK53; and G3PD1F, G3PD1R) are listed in Table 1 . For DNA sequence analysis, PCR products were ligated into the pT7Blue plasmid (Novagen) and insertcontaining plasmids sequenced on both strands using Sequenase (US Biochemical).
Chromosomal localization
PCR of genomic DNA from somatic cell hybrids (BIOS Laboratories) or radiation hybrids (Stanford G3 panel, Research Genetics) was performed as described above. Linkage to framework markers was determined using the Stanford Human Genome Center's Radiation Hybrid server (http://www-shgc.stanford.edu/RH/index.html).
Linkage analysis was performed using RHMAP version 3.0 (Boehnke et al., 1991) .
Pulsed ®eld gel electrophoresis
Cells were embedded in 0.5% low melting point agarose at 2 million cells per ml, treated with 0.5 M EDTA, 1% sarcosyl, and 0.5 mg/ml proteinase K at 508C for 2 days, followed by washing with 10 mM TrisHCl (pH 7.4), 1 mM EDTA, and 1 mM phenylmethylsulfonyl¯uoride (Sigma). Agarose blocks were digested with appropriate restriction enzymes for 12 h and electrophoresis was performed in 1% agarose (Pulsed Field Certi®ed Agarose, Bio-Rad Laboratories) with CHEF mapper (Bio-Rad Laboratories) at 6 V/ cm with pulse time 3 min 25 s for 18 h in 0.56Tris-borate EDTA buer. Blotting and hybridization were performed as described above.
